FiO2 Closed Loop Control Ventilation

NCT02810080 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2024-08-15

Study results available
· View outcomes & findings →

Summary

A randomized, multi-center trial involving critically-ill patients comparing conventional, manual control of inspired oxygen (FiO2) within a target range, with a computer-controlled, closed-loop FiO2 delivery using a continuous ventilator.

Conditions

Interventions

DEVICE

Closed Loop Control Ventilation

Closed loop control ventilation using ZOLL 731 ventilator with physiologic closed-loop control software

DEVICE

Manual Control Ventilation

Manual control ventilation using ZOLL 731 ventilator

Sponsors & Collaborators

  • United States Air Force

    collaborator FED
  • Zoll Medical Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02810080 on ClinicalTrials.gov